TerrAscend (TSNDF) Shares Outstanding (Diluted Average) (2020 - 2026)
TerrAscend (TSNDF) reported Shares Outstanding (Diluted Average) of $308.5 million for Q1 2026, up 5.26% year-over-year from $293.1 million in Q1 2025, and up 2.47% quarter-over-quarter from $301.1 million in Q4 2025.
TerrAscend (TSNDF) Shares Outstanding (Diluted Average) (2020 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 7 years of Shares Outstanding (Diluted Average) data on file, last reported at $308.5 million in Q1 2026.
- Shares Outstanding (Diluted Average) for Q1 2026 came in at $308.5 million, up 5.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $308.5 million (up 5.26% YoY), and the FY2025 annual result was $301.1 million, up 3.28% from the prior year.
- Shares Outstanding (Diluted Average) grew to $308.5 million in Q1 2026 per TSNDF's latest filing, from $301.1 million in the prior quarter.
- Over five years, Shares Outstanding (Diluted Average) peaked at $308.5 million in Q1 2026 and troughed at $211.1 million in Q1 2022.
- A 5-year average of $277.0 million and a median of $290.6 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Diluted Average) slumped 99.88% in 2022, then gained 26.56% in 2023.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $244.4 million in 2022, then climbed by 14.3% to $279.3 million in 2023, then advanced by 4.38% to $291.5 million in 2024, then rose by 3.28% to $301.1 million in 2025, then rose by 2.47% to $308.5 million in 2026.
- Business Quant data shows TSNDF's Shares Outstanding (Diluted Average) at $308.5 million in Q1 2026, $301.1 million in Q4 2025, and $306.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | TerrAscend | - | - | 34.60 Mn | 308.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 308.53 Mn |
| Dec 31, 2025 | 301.08 Mn |
| Sep 30, 2025 | 306.30 Mn |
| Jun 30, 2025 | 296.14 Mn |
| Mar 31, 2025 | 293.12 Mn |
| Dec 31, 2024 | 291.51 Mn |
| Sep 30, 2024 | 291.25 Mn |
| Jun 30, 2024 | 291.05 Mn |
| Mar 31, 2024 | 290.62 Mn |
| Dec 31, 2023 | 279.29 Mn |
| Sep 30, 2023 | 276.56 Mn |
| Jun 30, 2023 | 275.19 Mn |
| Mar 31, 2023 | 267.21 Mn |
| Dec 31, 2022 | 244.35 Mn |
| Sep 30, 2022 | 254.36 Mn |
| Jun 30, 2022 | 231.83 Mn |
| Mar 31, 2022 | 211.13 Mn |
| Dec 31, 2021 | 208.71 Mn |
| Sep 30, 2021 | 214.76 Bn |
| Jun 30, 2021 | 176.90 Bn |